News

Discover
Journals
Momentum
Rankings
Elections
Local
Trending
Latest
Top Stories
Rising
Controversial
Bubble Gap

Log in

Get above the noise

Log in for answers tailored to you — saved chats, your topics, and the full IJR suite.

Forte Group — news, coverage & facts — IJR

|NewsJournalsOrganizationForte Group

Forte Group — Richard Dear · CC BY-SA 2.0

Organization

Forte Group

defunct British hotel and restaurant company

4 members

Feed News Media Community Map About

4 memberscoverage spread: L0/C50/R50

Comments

Ask this entity anything:

☺

Free account · your comment posts right after signup

Photo: Polina Tankilevitch / Wikimedia Commons (Pexels)
Argenx plans $2.2B Forte Biosciences deal
Argenx has agreed to acquire Forte Biosciences for about $2.2 billion in cash, offering $77 per Forte share and funded entirely from Argenx’s cash to complete a Q3 2026 closing after standard approvals and tender conditions. The deal adds Forte’s FB102, a first-in-class CD122 antibody for vitiligo and celiac disease with potential broader autoimmune applications, boosting Argenx's immunology pipeline beyond Vyvgart.
17 sources

Facts from Wikidata (CC0). Image via Wikimedia Commons (CC BY-SA 2.0).